0001493152-22-016079.txt : 20220607 0001493152-22-016079.hdr.sgml : 20220607 20220607160546 ACCESSION NUMBER: 0001493152-22-016079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220606 FILED AS OF DATE: 20220607 DATE AS OF CHANGE: 20220607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alvino Mark CENTRAL INDEX KEY: 0001356828 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 221001274 MAIL ADDRESS: STREET 1: C/O SCO SECURITIES LLC STREET 2: 1285 AVENUE OF THE AMERICAS 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-813-4701 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2022-06-06 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001356828 Alvino Mark 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 1 0 0 0 Common Stock 2022-06-06 4 S 0 35000 0.1561 D 47181 D Reflects the average weighted price of sales on June 6, 2022. The shares were sold in multiple transactions at prices ranging from $0.155 to $0.1617, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. /s/ Mark Alvino 2022-06-07